Barrera V - Search Results

1

Low-dose interleukin-2 promotes immune regulation in face transplantation: A pilot study.

Murakami N, Borges TJ, Win TS, Abarzua P, Tasigiorgos S, Kollar B, Barrera V, Ho Sui S, Teague JE, Bueno E, Clark RA, Lian CG, Murphy GF, Pomahac B, Riella LV. Murakami N, et al. Among authors: barrera v. Am J Transplant. 2023 Apr;23(4):549-558. doi: 10.1016/j.ajt.2023.01.016. Epub 2023 Feb 4. Am J Transplant. 2023. PMID: 36740193 Free PMC article.

2

Longitudinal immunological characterization of the first presensitized recipient of a face transplant.

Win TS, Murakami N, Borges TJ, Chandraker A, Murphy G, Lian C, Barrera V, Ho Sui S, Schoenfeld D, Teague J, Bueno E, Tullius SG, Pomahac B, Clark RA, Riella LV. Win TS, et al. Among authors: barrera v. JCI Insight. 2017 Jul 6;2(13):e93894. doi: 10.1172/jci.insight.93894. eCollection 2017 Jul 6. JCI Insight. 2017. PMID: 28679959 Free PMC article.

3

Immunoregulatory and lipid presentation pathways are upregulated in human face transplant rejection.

Win TS, Crisler WJ, Dyring-Andersen B, Lopdrup R, Teague JE, Zhan Q, Barrera V, Ho Sui S, Tasigiorgos S, Murakami N, Chandraker A, Tullius SG, Pomahac B, Riella LV, Clark RA. Win TS, et al. Among authors: barrera v. J Clin Invest. 2021 Apr 15;131(8):e135166. doi: 10.1172/JCI135166. J Clin Invest. 2021. PMID: 33667197 Free PMC article. Clinical Trial.

4

Metastable Atrial State Underlies the Primary Genetic Substrate for MYL4 Mutation-Associated Atrial Fibrillation.

Ghazizadeh Z, Kiviniemi T, Olafsson S, Plotnick D, Beerens ME, Zhang K, Gillon L, Steinbaugh MJ, Barrera V, Sui SH, Werdich AA, Kapur S, Eranti A, Gunn J, Jalkanen J, Airaksinen J, Kleber AG, Hollmén M, MacRae CA. Ghazizadeh Z, et al. Among authors: barrera v. Circulation. 2020 Jan 28;141(4):301-312. doi: 10.1161/CIRCULATIONAHA.119.044268. Epub 2019 Nov 16. Circulation. 2020. PMID: 31735076 Free article.

5

Hepatic mTORC1 signaling activates ATF4 as part of its metabolic response to feeding and insulin.

Byles V, Cormerais Y, Kalafut K, Barrera V, Hughes Hallett JE, Sui SH, Asara JM, Adams CM, Hoxhaj G, Ben-Sahra I, Manning BD. Byles V, et al. Among authors: barrera v. Mol Metab. 2021 Nov;53:101309. doi: 10.1016/j.molmet.2021.101309. Epub 2021 Jul 23. Mol Metab. 2021. PMID: 34303878 Free PMC article.

6

DOCK8 enforces immunological tolerance by promoting IL-2 signaling and immune synapse formation in Tregs.

Janssen E, Kumari S, Tohme M, Ullas S, Barrera V, Tas JM, Castillo-Rama M, Bronson RT, Usmani SM, Irvine DJ, Mempel TR, Geha RS. Janssen E, et al. Among authors: barrera v. JCI Insight. 2017 Oct 5;2(19):e94298. doi: 10.1172/jci.insight.94298. JCI Insight. 2017. PMID: 28978806 Free PMC article.

7

Perivascular Fibrosis Is Mediated by a KLF10-IL-9 Signaling Axis in CD4+ T Cells.

Zhuang R, Chen J, Cheng HS, Assa C, Jamaiyar A, Pandey AK, Pérez-Cremades D, Zhang B, Tzani A, Khyrul Wara A, Plutzky J, Barrera V, Bhetariya P, Mitchell RN, Liu Z, Feinberg MW. Zhuang R, et al. Among authors: barrera v. Circ Res. 2022 May 27;130(11):1662-1681. doi: 10.1161/CIRCRESAHA.121.320420. Epub 2022 Apr 20. Circ Res. 2022. PMID: 35440172 Free PMC article.

8

Whole-genome CRISPR screening identifies genetic manipulations to reduce immune rejection of stem cell-derived islets.

Sintov E, Nikolskiy I, Barrera V, Hyoje-Ryu Kenty J, Atkin AS, Gerace D, Ho Sui SJ, Boulanger K, Melton DA. Sintov E, et al. Among authors: barrera v. Stem Cell Reports. 2022 Sep 13;17(9):1976-1990. doi: 10.1016/j.stemcr.2022.08.002. Epub 2022 Sep 1. Stem Cell Reports. 2022. PMID: 36055241 Free PMC article.

9

Interferon Signaling Is Diminished with Age and Is Associated with Immune Checkpoint Blockade Efficacy in Triple-Negative Breast Cancer.

Sceneay J, Goreczny GJ, Wilson K, Morrow S, DeCristo MJ, Ubellacker JM, Qin Y, Laszewski T, Stover DG, Barrera V, Hutchinson JN, Freedman RA, Mittendorf EA, McAllister SS. Sceneay J, et al. Among authors: barrera v. Cancer Discov. 2019 Sep;9(9):1208-1227. doi: 10.1158/2159-8290.CD-18-1454. Epub 2019 Jun 19. Cancer Discov. 2019. PMID: 31217296

10

Molecular convergence between Down syndrome and fragile X syndrome identified using human pluripotent stem cell models.

Susco SG, Ghosh S, Mazzucato P, Angelini G, Beccard A, Barrera V, Berryer MH, Messana A, Lam D, Hazelbaker DZ, Barrett LE. Susco SG, et al. Among authors: barrera v. Cell Rep. 2022 Sep 6;40(10):111312. doi: 10.1016/j.celrep.2022.111312. Cell Rep. 2022. PMID: 36070702 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

88 results

Search Page